BiotechTube

FK463

Phase 2Completed
3 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis

Trial Timeline

Feb 27, 1999 → Jan 27, 2002

NCT ID
NCT00036179

About FK463

FK463 is a phase 2 stage product being developed by Astellas Pharma for Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00036179. Target conditions include Candidiasis.

What happened to similar drugs?

5 of 20 similar drugs in Candidiasis were approved

Approved (5) Terminated (4) Active (12)
✅Fluconazole + MicafunginAstellas PharmaApproved
✅Caspofungin + Normal SalineMerckApproved
✅VoriconazolePfizerApproved
✅Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)PfizerApproved
✅Clotrimazole vaginal tablet + FluconazoleBayerApproved
🔄Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
🔄Micafungin + fluconazoleAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00036179Phase 2Completed
NCT00036166Phase 2Completed

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + CaspofunginAstellas PharmaPhase 3
40
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43
caspofungin acetateMerckPhase 3
40